Guangzhou Baiyunshan Pharmaceutical

(OTC) GZPHF

Current Price$2.34

Market Cap$3.80B

Since IPO (2004)+1,070%

5 Year+15%

1 Year-15%

1 Month+9%

Guangzhou Baiyunshan Pharmaceutical Financials at a Glance

Market Cap

$3.80B

Revenue (TTM)

$77.99B

Net Income (TTM)

$2.93B

EPS (TTM)

$0.26

P/E Ratio

9.09

Dividend

$0.11

Beta (Volatility)

0.10 (Low)

Dividend

$0.11

Beta (Volatility)

0.10 (Low)

Price

$2.34

Volume

300

Open

$2.34

Price

$2.34

Volume

300

Open

$2.34

Previous Close

$2.34

Daily Range

$2.34 - $2.34

52-Week Range

$2.14 - $2.64

Dividend

$0.11

Beta (Volatility)

0.10 (Low)

Price

$2.34

Volume

300

Open

$2.34

Previous Close

$2.34

Daily Range

$2.34 - $2.34

52-Week Range

$2.14 - $2.64

GZPHF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guangzhou Baiyunshan Pharmaceutical

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

27,057

CEO

Hong Li, EMBA

Website

www.gybys.com.cn

Headquarters

Guangzhou, 510130, CN

GZPHF Financials

Key Financial Metrics (TTM)

Gross Margin

16%

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

11.00%

Dividend Yield

4.79%

Payout Ratio

69.49%

Stock Overview

Market Cap

$3.80B

Shares Outstanding

1.63B

Volume

300

Avg. Volume

Financials (TTM)

Gross Profit

$11.46B

Operating Income

$3.02B

EBITDA

$3.95B

Operating Cash Flow

$253.52M

Capital Expenditure

$1.21B

Free Cash Flow

$954.41M

Cash & ST Invst.

$23.82B

Total Debt

$20.70B

Guangzhou Baiyunshan Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$23.05B

+2.6%

Gross Profit

$4.68B

+1.6%

Gross Margin

20.31%

N/A

Market Cap

$3.80B

N/A

Market Cap/Employee

$135.20K

N/A

Employees

28,138

N/A

Net Income

$1.77B

-3.0%

EBITDA

$2.14B

-8.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.76B

-168.0%

Accounts Receivable

$26.93B

+12.2%

Inventory

$12.42B

+14.8%

Long Term Debt

$5.22B

+105.6%

Short Term Debt

$11.81B

+31.2%

Return on Assets

3.28%

N/A

Return on Invested Capital

6.62%

N/A

Free Cash Flow

$2.32B

+43.9%

Operating Cash Flow

$2.09B

+46.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HKMPFHikma Pharmaceuticals PLC

HKMPFHikma Pharmaceuticals PLC$18.10+0.00%

HKMPYHikma Pharmaceuticals PLC

HKMPYHikma Pharmaceuticals PLC$37.21+0.00%

DNPUFSumitomo Pharma Co., Ltd.

DNPUFSumitomo Pharma Co., Ltd.$11.43-1.47%

SHPMYShanghai Pharmaceuticals Holding Co., Ltd

SHPMYShanghai Pharmaceuticals Holding Co., Ltd$7.60+0.00%

OPHLFOno Pharmaceutical Co., Ltd.

OPHLFOno Pharmaceutical Co., Ltd.$14.55+0.00%

OPHLYOno Pharmaceutical Co., Ltd.

OPHLYOno Pharmaceutical Co., Ltd.$4.86-1.12%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About GZPHF

What is the current price of Guangzhou Baiyunshan Pharmaceutical?

Guangzhou Baiyunshan Pharmaceutical is trading at $2.34 per share.

What is the 52-week range for Guangzhou Baiyunshan Pharmaceutical?

Over the past 52 weeks, Guangzhou Baiyunshan Pharmaceutical has traded between $2.14 and $2.64.

How much debt does Guangzhou Baiyunshan Pharmaceutical have?

As of the most recent reporting period, Guangzhou Baiyunshan Pharmaceutical reported total debt of $3.40B.

How much cash does Guangzhou Baiyunshan Pharmaceutical have on hand?

Guangzhou Baiyunshan Pharmaceutical reported $1.78B in cash and cash equivalents in its most recent financial results.

What is Guangzhou Baiyunshan Pharmaceutical’s dividend yield?

Guangzhou Baiyunshan Pharmaceutical currently has a dividend yield of 4.79%.

Guangzhou Baiyunshan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical Financials at a Glance

GZPHF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Guangzhou Baiyunshan Pharmaceutical

GZPHF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Guangzhou Baiyunshan Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GZPHF

What is the current price of Guangzhou Baiyunshan Pharmaceutical?

What is the 52-week range for Guangzhou Baiyunshan Pharmaceutical?

How much debt does Guangzhou Baiyunshan Pharmaceutical have?

How much cash does Guangzhou Baiyunshan Pharmaceutical have on hand?

What is Guangzhou Baiyunshan Pharmaceutical’s dividend yield?

Premium Investing Services